BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15252936)

  • 1. Sex hormones and ApoE4: beyond steroids.
    Bowen RL; Gregory CW
    J Alzheimers Dis; 2004 Jun; 6(3):229-30. PubMed ID: 15252936
    [No Abstract]   [Full Text] [Related]  

  • 2. apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene.
    Feuk L; Prince JA; Breen G; Emahazion T; Carothers A; St Clair D; Brookes AJ
    Hum Genet; 2000 Oct; 107(4):391-6. PubMed ID: 11129341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Alzheimer-apoE4 connection].
    Jørgensen AL
    Ugeskr Laeger; 1993 Nov; 155(48):3936-7. PubMed ID: 8273205
    [No Abstract]   [Full Text] [Related]  

  • 4. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
    Spell C; Kölsch H; Lütjohann D; Kerksiek A; Hentschel F; Damian M; von Bergmann K; Rao ML; Maier W; Heun R
    Dement Geriatr Cogn Disord; 2004; 18(3-4):245-9. PubMed ID: 15286454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoE4: is it the absence of good or the presence of bad?
    Ashford JW
    J Alzheimers Dis; 2002 Jun; 4(3):141-3. PubMed ID: 12226532
    [No Abstract]   [Full Text] [Related]  

  • 6. Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses.
    Saunders AM
    J Neuropathol Exp Neurol; 2000 Sep; 59(9):751-8. PubMed ID: 11005255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E and its association with Alzheimer's disease.
    Perls TT
    J Insur Med; 1996; 28(2):114-8. PubMed ID: 10172880
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's disease: the genetics of risk.
    Roses AD
    Hosp Pract (1995); 1997 Jul; 32(7):51-5, 58-63, 67-9. PubMed ID: 9227658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease.
    Wang PN; Liu HC; Liu TY; Chu A; Hong CJ; Lin KN; Chi CW
    Dement Geriatr Cogn Disord; 2005; 19(2-3):120-5. PubMed ID: 15591802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting?
    Bliwise DL
    J Psychosom Res; 2002 Jul; 53(1):539-46. PubMed ID: 12127169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E4 allele frequency in Spanish Alzheimer and control cases.
    Adroer R; Santacruz P; Blesa R; López-Pousa S; Ascaso C; Oliva R
    Neurosci Lett; 1995 Apr; 189(3):182-6. PubMed ID: 7624040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New piece in Alzheimer's puzzle.
    Travis J
    Science; 1993 Aug; 261(5123):828-9. PubMed ID: 8346434
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's disease. The apolipoprotein E connection.
    Utermann G
    Curr Biol; 1994 Apr; 4(4):362-5. PubMed ID: 7922348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a protective allele against Alzheimer disease in the APOE gene promoter.
    Beyer K; Lao JI; Gómez M; Riutort N; Latorre P; Mate JL; Ariza A
    Neuroreport; 2002 Aug; 13(11):1403-5. PubMed ID: 12167762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E: a pharmacogenetic target for the treatment of Alzheimer's disease.
    Poirier J
    Mol Diagn; 1999 Dec; 4(4):335-41. PubMed ID: 10671644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type.
    Regland B; Blennow K; Germgård T; Koch-Schmidt AC; Gottfries CG
    Dement Geriatr Cogn Disord; 1999; 10(4):245-51. PubMed ID: 10364640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasma lipidic pattern.
    Scacchi R; Gambina G; Martini MC; Ruggeri M; Ferrari G; Silvestri M; Schiavon R; Corbo RM
    Dement Geriatr Cogn Disord; 2001; 12(2):63-8. PubMed ID: 11173876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE: crossroads between Alzheimer's disease and atherosclerosis.
    Stojakovic T; Scharnagl H; März W
    Semin Vasc Med; 2004 Aug; 4(3):279-85. PubMed ID: 15630629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease.
    Beffert U; Danik M; Krzywkowski P; Ramassamy C; Berrada F; Poirier J
    Brain Res Brain Res Rev; 1998 Jul; 27(2):119-42. PubMed ID: 9622609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE and the regulation of microglial nitric oxide production: a link between genetic risk and oxidative stress.
    Colton CA; Brown CM; Cook D; Needham LK; Xu Q; Czapiga M; Saunders AM; Schmechel DE; Rasheed K; Vitek MP
    Neurobiol Aging; 2002; 23(5):777-85. PubMed ID: 12392781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.